A detailed history of Ascension Asset Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Ascension Asset Management LLC holds 3,140 shares of LLY stock, worth $2.5 Million. This represents 1.48% of its overall portfolio holdings.

Number of Shares
3,140
Previous 3,190 1.57%
Holding current value
$2.5 Million
Previous $2.48 Million 14.55%
% of portfolio
1.48%
Previous 1.36%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

SELL
$724.87 - $909.04 $36,243 - $45,452
-50 Reduced 1.57%
3,140 $2.84 Million
Q1 2024

May 10, 2024

BUY
$592.2 - $792.28 $23,688 - $31,691
40 Added 1.27%
3,190 $2.48 Million
Q2 2023

Aug 10, 2023

BUY
$350.74 - $468.98 $1.1 Million - $1.48 Million
3,150 New
3,150 $1.48 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Ascension Asset Management LLC Portfolio

Follow Ascension Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ascension Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ascension Asset Management LLC with notifications on news.